A case of a geriatric patient with thrombocytopenia after partial recovery from COVID-19

2024-9-6

Dosing strategy of tacrolimus when co-administered with Wuzhi tablet in renal transplant recipients

2024-8-19

Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial

2024-8-19

Early acute kidney injury after tacrolimus administration in heart transplant recipients receiving basiliximab induction therapy

2024-8-9

Pulmonary fibrosis insights and therapy targets from disease models and administration of the lipophilic diterpene, sodium tanshinone IIA sulfonate: Review and meta-analysis

2024-8-9

Evaluation of metronidazole oral monotherapy in anaerobic oral infections

2024-8-9

Post-marketing safety concerns with montelukast: A pharmacovigilance study based on the FDA adverse event reporting system

2024-8-5

Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects

2024-7-30

Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional study

2024-7-30

Chronic myeloid leukemia in an ulcerative colitis patient receiving azathioprine: A case report

2024-7-24

A decision tree model for predicting high mono-N-desethylamiodarone concentrations and reducing tissue toxicity in patients with low-dose amiodarone therapy: A multicentral retrospective cohort study

2024-7-24

Rational use of short-term anorectic drugs for one-year effective treatment of obesity: An analysis of four studies

2024-7-24

Population pharmacokinetic study and application of ticagrelor and AR-C124910XX after percutaneous coronary intervention in Chinese patients with acute coronary syndrome

2024-7-22

A case study of impaired consciousness caused by alcohol consumption in a pediatric patient taking high-dose cefixime

2024-7-22

Evidence-based clinical pharmacology using network analysis of the curcumacontaining traditional Chinese medication Changpu-Yujin: Efficacy in the treatment of insomnia

2024-7-4

Calcineurin inhibitors experience in unplanned pregnancies with active lupus disease: A retrospective observational study

2024-7-1

Degree of serum LDL cholesterol reduction by simvastatin and ezetimibe is dependent on baseline LDL cholesterol concentration but not on baseline values and changes of cholesterol synthesis and absorption parameters

2024-7-1

Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learned for future use

2024-6-26

Membrane P-glycoprotein expression in lymphocytes from adult patients with refractory glomerulonephritis

2024-6-26

Alleviation of severe chronic arthritic pain using polyvalent immunoglobulins (KMP01): Two case reports

2024-6-25

Network pharmacology analysis and molecular docking using the Chinese herbal agent WYHX formula (according to Yan Dexin): Management of coronary artery disease

2024-6-25

Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen

2024-6-1

Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis

2024-6-1

Risk factors for infliximab-induced infusion reactions based on a retrospective study of medical information

2024-5-10

Activated charcoal helps in the diagnosis of dabigatran overdose: A case study

2024-5-10

Pegylated-interferon alpha (PEG-IFNα)-induced interstitial lung disease in a patient with chronic hepatitis B: A case report and literature review

2024-5-3

Palatability evaluation of orally disintegrating tablets using a visual analog scale in clinical trials

2024-5-3

Comparison of SB17 and reference ustekinumab in healthy adults: A randomized, double-blind, single-dose, phase I study

2024-5-1

Efficacy and safety of antiplatelet therapy in COVID-19: Insights from a meta-analysis of randomized controlled trials

2024-5-1

A cross-sectional study on the potential drug-drug interaction risk of COVID-19 patients in hospital

2024-4-25

Pharmacokinetics of apixaban in patients undergoing pancreaticoduodenectomy (PAP-UP)

2024-4-25

Acute liver failure caused by high-dose tigecycline: A case report

2024-4-12

Clinical Handbook of Psychotropic Drugs for Children and Adolescents (5th Edition)

2024-4-5

A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects

2024-4-5

Network target theory and network pharmacology: Next generation drug research in medicine using AI models

2024-4-1

Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 1: Biogenic components and identification of targets and signaling pathways in amyotrophic lateral sclerosis patients

2024-4-1

Network pharmacology analysis of the renal protective effects of bracken (Pteridium aquilinum) using experimental data obtained in an avian (quail) hyperuricemia model

2024-4-1

Primary and secondary prevention of stroke and cardiovascular events using evolocumab and alirocumab: Meta-analysis of randomized controlled trials

2024-3-26

Therapeutic drug monitoring of vancomycin in surgical patients through a validated HPLC method

2024-3-26

Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report

2024-3-3

Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 3: Alleviation of hypoxia, muscle-wasting, and modulation of redox functions in amyotrophic lateral sclerosis

2024-3-3

Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 2: Modulation of hypoxia, redox status, and mitochondrial protection in a neuroblastoma cell line, SH-SY5Y

2024-3-3

Low albumin combined with low-molecular-weight heparin as risk factors for liver injury using azvudine: Evidence from an analysis of COVID-19 patients in a national prospective pharmacovigilance database

2024-3-3

Clinical and research implications of uricase knockout and renal injury

2024-3-3

Evaluation of the risk factors for the failure of a single prophylactic dose of anticholinergic drugs for irinotecan-induced cholinergic symptoms

2024-3-3

Subcutaneous infliximab CT-P13 without intravenous induction in psoriatic arthritis: A case report and pharmacokinetic considerations

2024-3-1

Can non-renal clearance and/or bioavailability of drugs be assessed reliably in renal impairment studies with oral drug administration?

2024-3-1

Pharmacokinetics and bioequivalence of tofacitinib 5 mg in healthy Korean male subjects

2024-3-1

Incidence and risk factors associated with augmented renal clearance in critically ill patients

2024-3-1

Cost-effectiveness analysis of mecapegfilgrastim and recombinant human granulocyte stimulating factor for primary prophylaxis of chemotherapy-induced neutropenia in non-small cell lung cancer

2024-3-1